CNBC's Jim Cramer on Wednesday identified two biotechnology stocks that he thinks could climb.» Read More
Sometimes data provides a valuable read on the economy. Other times, the Street just thinks it does.
Do you worry about saving enough so you won't run out of money in your golden years? You might actually be saving too much for retirement.
Despite a recent downward GDP revision, a couple of sectors still stand to perform well, Morgan Stanley's Adam Parker says.
Gloom and doomers are getting worked up about a potential spike in volatility but Ron Insana says hang on, we're not on the fast track to catastrophe.
Check out which companies are making headlines before the bell.
Will the Macarena once again sweep the nation? Maybe not, but some still say it feels like 1996. Here's why some are bracing for a quick correction.
Stocks reverse course, retreating from record highs set earlier in the day. Weakness in energy stocks causes selling.
Cramer knows those big mutual funds are trying to win your money. He says don’t give it to them.
Tony Dwyer has the highest S&P target on the Street. So why is he calling for a 10 percent drop?
Vertex Pharmaceuticals' spike Tuesday had investors looking for the next breakout stock. UBS's Matt Roden likes these names.
Officials are subpoenaing Dean Foods for information on activist investor Carl Icahn and golfer Phil Mickelson, the Wall Street Journal reports.
Take a look at some of Tuesday's midday movers.
A sell-off could be on the way, a leading fund manager warned, describing the low-interest-rate environment as like "Alice in Wonderland."
Check out which companies are making headlines after the bell Tuesday.
It's good to be prepared, but you don't have to keep all your money in a bank.
Michael Aronstein of MainStay Marketfield Fund criticized Fed policy but said he had increased stock exposure.
Student loan debt may be among the biggest issues facing younger Americans.
Is the company 401(k) a better way to invest for retirement? Or should you go with an IRA?
Dennis Gartman of "The Gartman Letter" says oil traders should keep a close eye on Nigeria.
Inflationary pressures give you a good reason to short this stock, argues Sterne Agee chief market technician Carter Worth.
Get the best of CNBC in your inbox